Literature DB >> 19383415

The changing landscape of European and international regulation on embryonic stem cell research.

A Elstner1, A Damaschun, A Kurtz, G Stacey, B Arán, A Veiga, J Borstlap.   

Abstract

Legislation in individual member states of the European Union on human embryonic stem cell (hESC) research is as divergent as the different cultural, ethical, and religious views on the issue. On the occasion of the public launch of the European Human Embryonic Stem Cell Registry (hESCreg: www.hescreg.eu), a two-day symposium was held on 18 and 19 January 2008 in Berlin to offer participants an overview of state-of-the-art hESC research and legislation throughout Europe and in selected regions of the world. Thirty leading scientists from Europe as well as from the United States, Japan, and Australia reported on a range of aspects related to research on hESC and reviewed the key elements of the newly established hESCreg database of hESC lines. In this article we summarize and complete the information on the current status of international hESC regulation.

Entities:  

Mesh:

Year:  2008        PMID: 19383415     DOI: 10.1016/j.scr.2008.10.003

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  8 in total

1.  Developments and challenges in human embryonic stem cell research in Spain.

Authors:  R P Cervera; M Stojkovic
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

Review 2.  Policy interoperability in stem cell research: demystifying harmonization.

Authors:  Rosario M Isasi
Journal:  Stem Cell Rev Rep       Date:  2009-03-31       Impact factor: 5.739

Review 3.  International stem cell registries.

Authors:  Joeri Borstlap; Mai X Luong; Heather M Rooke; B Aran; A Damaschun; A Elstner; Kelly P Smith; Gary S Stein; Anna Veiga
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

4.  New Advances in Human X chromosome status from a Developmental and Stem Cell Biology.

Authors:  Benjamin Patterson; Yoshiaki Tanaka; In-Hyun Park
Journal:  Tissue Eng Regen Med       Date:  2017-11-22       Impact factor: 4.169

5.  Patients' views on using human embryonic stem cells to treat Parkinson's disease: an interview study.

Authors:  Jennifer Drevin; Dag Nyholm; Håkan Widner; Trinette Van Vliet; Jennifer Viberg Johansson; Elena Jiltsova; Mats Hansson
Journal:  BMC Med Ethics       Date:  2022-10-19       Impact factor: 2.834

6.  Human embryonic stem cell lines and their use in international research.

Authors:  Peter Löser; Jacqueline Schirm; Anke Guhr; Anna M Wobus; Andreas Kurtz
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

Review 7.  Immunomodulation and Regenerative Capacity of MSCs for Long-COVID.

Authors:  Xin Ya Loke; Siti A M Imran; Gee Jun Tye; Wan Safwani Wan Kamarul Zaman; Fazlina Nordin
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

8.  A survey of Italian physicians' opinion about stem cells research: what doctors prefer and what the law requires.

Authors:  Paola Frati; Matteo Gulino; Arianna Pacchiarotti; Stefano D'Errico; Lorella Sicuro; Vittorio Fineschi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.